Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2000
08/23/2000EP1029872A1 Piperazine-cyclodextrin complexes
08/23/2000EP1029586A2 Emulsifiers
08/23/2000EP1029551A2 Nitrogen monoxide metabolite-polyoxyalkylene-hemoglobin complex
08/23/2000EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
08/23/2000EP1029544A1 Intra-cancer-cell nuclease activator
08/23/2000EP1029543A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
08/23/2000EP1029542A1 Percutaneously absorbable preparation
08/23/2000EP1029539A1 Pharmaceutical filled hard capsules
08/23/2000EP1029537A1 Sustained release eyedrops
08/23/2000EP1029458A2 Antiallergic composition and antipruritic composition
08/23/2000EP1029070A1 Transfecting peptide vector, composition containing same and applications
08/23/2000EP1028991A1 Strictly alternating poly(alkylene oxide ether) copolymers
08/23/2000EP1028978A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/23/2000EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers
08/23/2000EP1028969A2 New sophoroselipids, method for their production and use
08/23/2000EP1028758A1 Methods for treating prostate tumors using radioactive compositions
08/23/2000EP1028757A1 Radioactive embolizing compositions
08/23/2000EP1028756A1 Water soluble paclitaxel derivatives
08/23/2000EP1028753A1 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels
08/23/2000EP1028752A2 Platelet substitutes and conjugation methods suitable for their preparation
08/23/2000EP1028748A1 Compositions providing for increased igf-i solubility
08/23/2000EP1028746A1 Method for producing igf-i sustained-release formulations
08/23/2000EP1028731A2 Stable antiandrogenic gel composition
08/23/2000EP1028730A1 Compositions of lipid lowering agents
08/23/2000EP1028727A1 Skin penetration enhancing components
08/23/2000EP1028723A1 Stabilized ascorbic acid, composition, and method of use
08/23/2000EP1028720A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness
08/23/2000EP1028718A2 Extended release formulation containing venlafaxin
08/23/2000EP1028715A1 Dosage composition for nasal delivery and method of use of the same
08/23/2000EP1028713A1 A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
08/23/2000EP1028712A2 Solid solution beadlet
08/23/2000EP1028710A1 Topical compositions for nsai drug delivery
08/23/2000EP1028709A1 Novel once-a-day controlled release sulfonylurea formulation
08/23/2000EP1028708A1 Topical compositions for prostaglandin e 1? delivery
08/23/2000EP1028707A1 Sustained release ophthalmic compositions containing water soluble medicaments
08/23/2000EP1028706A1 Buffered drug formulations for transdermal electrotransport delivery
08/23/2000EP0907664B1 Oxidized oligosaccharides
08/23/2000EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
08/23/2000EP0726920B1 Process for preparing high molecular weight polyesterpolycarbonates
08/23/2000EP0684840B1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method
08/23/2000EP0674506B1 Controlled release growth hormone containing microspheres
08/23/2000EP0587738B1 Targeted delivery of genes encoding secretory proteins
08/23/2000EP0584247B1 Compositons for the treatment of chronic fatigue syndrome
08/23/2000CN1264321A Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
08/23/2000CN1264310A Polymer based pharmaceutical compositions for targeted delivery of biologically active agents
08/23/2000CN1264309A Biofunctional polymers prepared in supercritical fluid
08/23/2000CN1264304A Lipid-based immune modulator composition
08/23/2000CN1264299A Improved rapidly disintegratable multiparticulate tablet
08/23/2000CN1264298A Bright white film coatings and film coating compositions therefor
08/23/2000CN1264295A Lipid complexes and liposomes of highly insoluble platinum complexes
08/23/2000CN1055618C Method for preparing prolonged release microcapsules
08/23/2000CN1055617C Oral medicament form
08/22/2000US6107500 By reaction of sorbitol with triglycerides in the presence of an alkaline catalyst and cocatalyst comprising a product of the reaction as seld-emulsifer, or an specified amidoamine, where cyclic sorbitol ester formation is avoided
08/22/2000US6107499 Dopamine analog amide
08/22/2000US6107416 Hydrophobic polymer backbone having a free reactive group independent of any urethane linkages and a hydrophilic spacer group bonded to the polymer and a biomolecule (antibiotic, heparin at the other); surgery; bioeffective separation space
08/22/2000US6107333 Parenteral paclitaxel in a stable non-toxic formulation
08/22/2000US6107290 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof
08/22/2000US6107286 Complexing with nucleic acids
08/22/2000US6107285 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
08/22/2000US6107282 Treatment of C. difficile toxin B associated conditions
08/22/2000US6107281 Compounds and their combinations for the treatment of influenza infection
08/22/2000US6107102 Therapeutic microdevices and methods of making and using same
08/22/2000US6106866 In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
08/22/2000US6106865 Mixture of microcrystalline cellulose, compressibility, silica and surfactants
08/22/2000US6106864 Pharmaceutical formulations containing darifenacin
08/22/2000US6106863 Sustained-release metal valproate tablets
08/22/2000US6106861 Tablets that disintegrate in the mouth
08/22/2000US6106860 Fatty ester of glycerol, diglycerol up to pentadecaglycerol as carriers for antibiotics
08/22/2000US6106859 Stabilization of lipid:DNA formulations during nebulization
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106856 Drug delivery through skin
08/22/2000US6106855 Wound healing agents of proteins, oil in water emulsions and applying to skin
08/22/2000US6106840 Autoimmune diseases
08/22/2000US6106835 Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
08/22/2000CA2183882C Pharmaceutical excipient having improved compressibility
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047725A1 Nitroreductase enzymes
08/17/2000WO2000047668A1 Freeze-dried agent containing paramylon, production and utilization thereof
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047607A1 A synthetic peptide disturbing intracellular signaling
08/17/2000WO2000047236A1 Matrices for drug delivery and methods for making and using the same
08/17/2000WO2000047234A1 Sustained release salts of pharmaceutically active peptides and their production
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047228A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
08/17/2000WO2000047213A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
08/17/2000WO2000047208A1 A transdermal composition of an antivomiting agent and a preparation containing the same
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047190A2 Method for producing film-type dosage forms
08/17/2000WO2000047189A1 Pharmaceutical effervescent formulation containing metamizol
08/17/2000WO2000047188A1 Oxadiazole compounds and compositions for delivering active agents
08/17/2000WO2000047186A1 Polynucleotide compositions for intramuscular and intradermal administration
08/17/2000WO2000047184A1 Skin sanitizing compositions
08/17/2000WO2000047177A1 Use of nanoscale chitosanes and/or chitosane derivatives
08/17/2000WO2000047175A1 Oral compositions and methods of production thereof
08/17/2000WO2000047174A1 Compositions for controlling bacterial colonization
08/17/2000WO2000047166A2 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047144A1 Prolonged release bioadhesive vaginal gel dosage form
08/17/2000WO2000047130A1 Injectable collagen-based system for delivery of cells or therapeutic agents
1 ... 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 ... 1712